Stryker Omega PEEK Knotless Anchor System

K202355 · Stryker · MBI · Nov 13, 2020 · Orthopedic

Device Facts

• Record ID: K202355
• Device Name: Stryker Omega PEEK Knotless Anchor System
• Applicant: Stryker
• Product Code: MBI · Orthopedic
• Decision Date: Nov 13, 2020
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3040
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Stryker Omega PEEK Knotless Anchor System is intended to be used for soft-tissue to bone fixation in the shoulder, foot/ankle, knee, hand/wrist, elbow, and hip. It is indicated for use in the following procedures: Shoulder: Rotator Cuff Repair, Bankart Repair, SLAP Lesion Repair, Biceps Tenodesis, Acromioclavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon Repair, Hallux Valgus Reconstruction, Mid-foot Reconstruction, Metatarsal Ligament Repair and Bunionectomy Knee: Medial Collateral Ligament Repair, Lateral Ligament Repair, Patellar Tendon Repair, Posterior Oblique Ligament Repair, Iliotibial Band Tenodesis, Secondary Fixation for ACL/PCL Reconstruction or Repair, Meniscal Root Repair Hand/Wrist: Scapholunate Ligament Reconstruction, Ulnar or Radial Collateral Ligament Reconstruction Elbow: Biceps Tendon Reattachment, Tennis Elbow Repair, Ulnar or Radial Collateral Reconstruction, Lateral Epicondylitis Repair Hip: Capsular Repair, Acetabular Labral Repair

Device Story

System comprises PEEK cannulated screws and separate PEEK eyelets; used for soft-tissue to bone fixation. Surgeon inserts eyelet and screw into bone, either directly or via pilot hole created by instrumentation; screws may be used without eyelet for suture fixation. Provided sterile in single-use barrier systems, preloaded on disposable screwdrivers/inserters or separate for manual loading. Suture threader included. Used in orthopedic surgical settings. Provides mechanical fixation of soft tissue to bone; benefits patient by stabilizing tissues during healing process.

Clinical Evidence

Bench testing only. Evaluated ultimate tensile strength, insertion, and cyclic displacement. Results showed equivalent pull-out strength to Predicate A and equivalent displacement to Predicate B. Biocompatibility testing performed per ISO 10993-1:2018; material-mediated pyrogenicity and bacterial endotoxin testing met required limits.

Technological Characteristics

Materials: PEEK (poly-ether-ether-ketone). Components: Cannulated screws, eyelets, disposable screwdrivers/inserters. Principle: Mechanical bone fixation fastener. Sterilization: Sterile, single-use. Connectivity: None.

Indications for Use

Indicated for soft-tissue to bone fixation in shoulder, foot/ankle, knee, hand/wrist, elbow, and hip procedures, including rotator cuff, Bankart, SLAP, biceps tenodesis, AC separation, deltoid, capsular shift/reconstruction, lateral/medial stabilization, Achilles, hallux valgus, mid-foot, metatarsal ligament, bunionectomy, MCL/LCL/patellar/posterior oblique ligament repair, IT band tenodesis, ACL/PCL secondary fixation, meniscal root repair, scapholunate/collateral ligament reconstruction, biceps reattachment, tennis elbow, and acetabular labral repair.

Regulatory Classification

Identification

A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

• Stryker All-PEEK Knotless Anchor System (K181083)
• Arthrex SwiveLock C Anchors (K173845)

Submission Summary (Full Text)

{0}------------------------------------------------

November 13, 2020

Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA logo on the right. The FDA logo includes a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.

Stryker Katie Farraro Staff Regulatory Affairs Specialist 5900 Optical Ct. San Jose, California 95138

Re: K202355

Trade/Device Name: Stryker Omega PEEK Knotless Anchor System Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth Or Threaded Metallic Bone Fixation Fastener Regulatory Class: Class II Product Code: MBI Dated: August 18, 2020 Received: August 19, 2020

Dear Katie Farraro:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

{1}------------------------------------------------

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

Laura C. Rose, Ph.D. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Food and Drug Administration

Expiration Date: 06/30/2020

510(k) Number (if known) K202355

Device Name Stryker Omega PEEK Knotless Anchor System

### Indications for Use (Describe)

The Stryker Omega PEEK Knotless Anchor System is intended to bone fixation in the shoulder, foot/ ankle, knee, hand/wrist, elbow, and hip.

It is indicated for use in the following procedures:

Shoulder: Rotator Cuff Repair, Bankart Repair, SLAP Lesion Repair, Biceps Tenodesis, Acromio-clavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction

Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon Repair, Hallux Valgus Reconstruction, Mid-foot Reconstruction, Metatarsal Ligament Repair and Bunionectomy

Knee: Medial Collateral Ligament Repair, Lateral Ligament Repair, Patellar Tendon Repair, Posterior Oblique Ligament Repair, Iliotibial Band Tenodesis, Secondary Fixation for ACL/PCL Reconstruction or Repair, Meniscal Root Repair

Hand/Wrist: Scapholunate Ligament Reconstruction, Ulnar or Radial Collateral Ligament Reconstruction

Elbow: Biceps Tendon Reattachment, Temis Elbow Repair, Unar or Radial Collateral Reconstruction, Lateral Epicondylitis Repair

Hip: Capular Repair, Acetabular Labral Repair

| Type of Use (Select one or both, as applicable) | |
|--------------------------------------------------------------------------------|-------------------------------------------------------------------------------|
| <div> <span> Prescription Use (Part 21 CFR 801 Subpart D) </span> </div> | <div> <span> Over-The-Counter Use (21 CFR 801 Subpart C) </span> </div> |

## CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

## *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESSBELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

# 510(k) Summary

#### I. SUBMITTER

Stryker Endoscopy 5900 Optical Ct. San Jose, CA 95138

| Contact Person: | Katie Farraro, PhD, RAC |
|-----------------|-------------------------------------|
| | Staff Regulatory Affairs Specialist |
| | Phone: [phone] |

Date Prepared: August 18, 2020

#### II. DEVICE

| Name of Device: | Stryker Omega PEEK Knotless Anchor System |
|----------------------|----------------------------------------------------------------------|
| Common Name: | Suture, Fastener, Fixation, Nondegradable, Soft Tissue |
| Classification Name: | Smooth or threaded metallic bone fixation fastener (21 CFR 888.3040) |
| Regulatory Class: | II |
| Product Code: | MBI |

#### III. PREDICATE DEVICE

Predicate A (Primary Predicate): Stryker All-PEEK Knotless Anchor System Company Name: Stryker 510(k) Number: K181083

Predicate B: Arthrex SwiveLock C Anchors Company Name: Arthrex 510(k) Number: K173845

#### IV. OBJECTIVE

The purpose of this Traditional 510(k) submission is to obtain Food and Drug Administration (FDA) authorization to market a modified Omega PEEK Knotless Anchor System. Specifically, this submission proposes two unrelated modifications to Stryker's legally marketed Omega system: 1) a modification to the anchor system's eyelet, and 2) an expansion in the indications for use to include meniscal root repair.

#### V. DEVICE DESCRIPTION

The Stryker Omega PEEK Knotless Anchor System consists of poly-ether-ether-ketone ("PEEK") cannulated screws with a separate PEEK eyelet. The anchor system is designed for insertion of the eyelet and screw into bone either directly or by using instrumentation for creation of a pilot hole. Alternatively, screws may be used without the eyelet for suture fixation in a pre-drilled pilot hole by means of a

{4}------------------------------------------------

cannulated screwdriver. Screws and eyelets may be provided either preloaded on respective disposable screwdrivers and inserters, or separately for manual loading. A suture threader is included with the eyelet inserter to facilitate loading of suture through the eyelet. Anchor systems are provided sterile and are packaged in single-use sterile barrier systems (SBS) that include one or more screws with or without eyelets.

#### VI. INTENDED USE

The Stryker Omega PEEK Knotless Anchor System is intended to be used for soft-tissue to bone fixation in the shoulder, foot/ankle, knee, hand/wrist, elbow, and hip.

It is indicated for use in the following procedures:

Shoulder: Rotator Cuff Repair, Bankart Repair, SLAP Lesion Repair, Biceps Tenodesis, Acromioclavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction

Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon Repair, Hallux Valgus Reconstruction, Mid-foot Reconstruction, Metatarsal Ligament Repair and Bunionectomy

Knee: Medial Collateral Ligament Repair, Lateral Ligament Repair, Patellar Tendon Repair, Posterior Oblique Ligament Repair, Iliotibial Band Tenodesis, Secondary Fixation for ACL/PCL Reconstruction or Repair, Meniscal Root Repair

Hand/Wrist: Scapholunate Ligament Reconstruction, Ulnar or Radial Collateral Ligament Reconstruction

Elbow: Biceps Tendon Reattachment, Tennis Elbow Repair, Ulnar or Radial Collateral Reconstruction, Lateral Epicondylitis Repair

Hip: Capsular Repair, Acetabular Labral Repair

### VII. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICES

The modified Omega PEEK Knotless Anchor System is identical to Predicate A (original Omega system) in terms of intended use, geometric design, operational principle, sterilization method, packaging, and shelf life. It is identical to Predicate B (SwiveLock C Anchors) in terms of intended use, indications for use, general design features, and operational principle. It is equivalent to both predicate devices in terms of materials intended for implantation and performance attributes. The minor differences between the modified Omega system and predicate devices do not raise new questions of safety and effectiveness, and these devices are substantially equivalent based on the criteria described in 21 CFR §807.100.

#### VIII. PERFORMANCE DATA

Non-clinical benchtop testing was conducted to evaluate the performance characteristics of the modified Stryker Omega PEEK Knotless Anchor System. Ultimate tensile strength (UTS) and insertion testing were performed to assess the proposed eyelet modification, and cyclic displacement testing was performed to demonstrate that the displacement of the modified Omega anchors is within a clinically

{5}------------------------------------------------

acceptable range for meniscal root repair. The modified Omega anchors demonstrated equivalent pull-out strength to the Predicate A devices and equivalent displacement to the Predicate B devices, and no new issues of safety and effectiveness were identified.

Biocompatibility testing was performed on the final finished devices per ISO 10993-1:2018 to confirm that the modified Omega system met all required biocompatibility testing endpoints. Testing for materialmediated pyrogenicity and bacterial endotoxins was also performed, with passing results below the required limits.

#### IX. CONCLUSIONS

The information presented within this Traditional premarket submission demonstrates that the modified Stryker Omega PEEK Knotless Anchor System is substantially equivalent to the predicate devices and will perform as safely and effectively within the intended use.